Is ERCP still the elective primary biliary drainage technique in patients with malignant distal biliary obstruction?

Juan J Vila; Vanesa Jusué Irurita; María Rullán Iriarte

doi:10.17235/reed.2023.10029/2023

Is ERCP still the elective primary biliary drainage technique in patients with malignant distal biliary obstruction?

Rev Esp Enferm Dig. 2024 Apr;116(4):182-185. doi: 10.17235/reed.2023.10029/2023.

Authors

Juan J Vila¹, Vanesa Jusué Irurita², María Rullán Iriarte²

Affiliations

¹ Endoscopy Unit. Gastroenterology Department, Hospital Universitario de Navarra, España.
² Endoscopy Unit. Gastroenterology Department, Hospital Universitario de Navarra.

PMID: 38095214
DOI: 10.17235/reed.2023.10029/2023

Abstract

Endoscopic retrograde cholangiopancreatography (ERCP) has been established as the first line therapy for the resolution of biliary and pancreatic diseases. The main disadvantage of the procedure is the rate of adverse events, around 10%1. So, despite being a minimally invasive procedure, ERCP has a non-negligible rate of adverse effects (AEs) and secondary mortality.

MeSH terms

Bile Duct Neoplasms* / complications
Cholangiopancreatography, Endoscopic Retrograde / adverse effects
Cholangiopancreatography, Endoscopic Retrograde / methods
Cholestasis* / diagnostic imaging
Cholestasis* / etiology
Cholestasis* / surgery
Drainage / adverse effects
Drainage / methods
Endosonography / adverse effects
Humans